MyCartis Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
51
- Latest Deal Type
-
Out of Business
MyCartis General Information
Description
Developer of immuno-diagnostic equipment designed to focus on oncology and in particular immuno-oncology. The company's equipment leverages quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real time, enabling clinical researchers to get accurate medical guidance with any sample.
Contact Information
Website
www.mycartis.netCorporate Office
- Industriepark Zwijnaarde 7C
- Zwijnaarde
- 9052 Ghent
- Belgium
Corporate Office
- Industriepark Zwijnaarde 7C
- Zwijnaarde
- 9052 Ghent
- Belgium
MyCartis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 16-Mar-2021 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Early Stage VC | 04-Sep-2014 | $19.9M | $19.9M | Completed | Generating Revenue |
MyCartis Comparisons
Industry
Financing
Details
MyCartis Competitors (17)
One of MyCartis’s 17 competitors is BioGenex Laboratories, a Corporation company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| Sera Prognostics | Formerly VC-backed | Salt Lake City, UT | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| RareCyte | Venture Capital-Backed | Seattle, WA | ||||
| Asuragen | Formerly VC-backed | Austin, TX |
MyCartis Patents
MyCartis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3512633-A1 | Prefilled cartridge | Inactive | 12-Oct-2016 | ||
| US-20200290038-A1 | Prefilled cartridge | Inactive | 12-Oct-2016 | ||
| WO-2018069056-A1 | Prefilled cartridge | Inactive | 12-Oct-2016 | ||
| WO-2018065417-A1 | Method for measuring avidity or functional affinity | Inactive | 03-Oct-2016 | ||
| AU-2016347740-A1 | Use of cd146 as a marker of the vascular wall tension | Inactive | 06-Nov-2015 | G01N33/575 |
MyCartis Signals
MyCartis FAQs
-
When was MyCartis founded?
MyCartis was founded in 2014.
-
Where is MyCartis headquartered?
MyCartis is headquartered in Ghent, Belgium.
-
What is the size of MyCartis?
MyCartis has 51 total employees.
-
What industry is MyCartis in?
MyCartis’s primary industry is Diagnostic Equipment.
-
Is MyCartis a private or public company?
MyCartis is a Private company.
-
What is MyCartis’s current revenue?
The current revenue for MyCartis is .
-
How much funding has MyCartis raised over time?
MyCartis has raised $19.9M.
-
Who are MyCartis’s competitors?
BioGenex Laboratories, Sera Prognostics, Foundation Medicine, RareCyte, and Asuragen are some of the 17 competitors of MyCartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process